Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Dec 4 2025
Jan 30 2026
Oct 24 2025
Sep 23 2025
Jan 28 2026